Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
- Sponsor
- Tongji Hospital
- Study ID
- NCT07177534
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Female Infertility
- Uterine Fibroids
Eligibility Criteria
- Sex
- FEMALE
- Age
- 20 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHERThis study is a retrospective observational study without intervention.
Study Details
Female fertility may be affected by uterine fibroids, although this association has not been elucidated. Our retrospective study has already constructed a predictive model for infertility risk in patients with uterine fibroids using machine learning. We will now validate and optimize this model through a prospective study
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- Sep 2025
- Primary completion
- Sep 30, 2031
- Completion
- Sep 30, 2031
Study Design
- Enrollment
- 7,084 participants (estimated)
Arms
- Arm: UFs with infertile patientsUterine fibroids combined with infertile women
- Arm: UFs with non-infertile patientsUterine fibroids combined with non-infertile women
Primary Outcome Measure
The pregnancy rate of women with uterine fibroids. [ Time Frame: through study completion, an average of 5 years ]
Central Contacts
- Wenwen Wang, PhD+86 15927167698
Related Studies
- Uterine Transplant in Absolute Uterine Infertility (AUIF)PHASE2/PHASE3 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Autologous Ovarian Tissue TransplantationRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPHASE3 · Recruiting · Sumitomo Pharma Switzerland GmbH · Mobile, Alabama
- An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related SymptomsRecruiting · Zenchi, Inc. · Las Vegas, Nevada